Eye-Tracking app could spot MS earlier
NCT ID NCT05776511
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a tablet-based eye-tracking app (eVOG) can detect subtle eye movement problems in people with brain MRI abnormalities (white matter lesions). The goal is to see if these eye movement patterns can help diagnose multiple sclerosis or related conditions. Researchers will compare results from 150 participants and healthy controls to determine the app's diagnostic value.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
eVOG (mobile video oculography app on a tablet)
What this could lead to
If successful, this could provide a simple, non-invasive tool to help doctors diagnose multiple sclerosis earlier and more accurately.
What could go wrong
This is an early-stage diagnostic study, not a treatment trial. The eye-tracking method may not reliably distinguish between different causes of white matter lesions, and results may not apply to broader populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nice University Hospital
RECRUITINGNice, 06000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact